Drug
Lafutidine clinical trials
How studies write it
Studies that test it under each name
Name
- Lafutidine
- 5
Studies by the year they started
5 studies that test it; most in 2005 (2)
| Year | Studies |
|---|---|
| 2005 | 2 |
| 2011 | 1 |
| 2015 | 1 |
| 2016 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 4 · Other 1
Boryung Pharmaceutical Co., Ltd (3) · Wuhan Union Hospital, China (1) · Taiho Pharmaceutical Co., Ltd. (1)
Often tested with
Tested in the same studies.
Related medicines
As reviewed, each with the page that says it.
- One of Antacids source
- One of Histamine H2 Antagonists source
Studies
Open first, then newest update. How each study uses lafutidine is read from its arms, and is right about nine times in ten.
Testing it · 5
- A Multi-center, Randomized, Double-blind Phase III Clinical Trial to Assess and Compare to the Efficacy and Safety of Lafutidine, Famotidine and Omeprazole-referenced in Korean Erosive Esophagitis PatientsCompletedPhase 3Boryung Pharmaceutical Co., LtdNCT01499368Written as Lafutidine
- A Study to Compare the Pharmacokinetics of Lafutidine and Irsogladine Maleate TabletCompletedPhase 1Boryung Pharmaceutical Co., LtdNCT02759224Written as Lafutidine
- The Drug-drug Interaction and Safety of Lafutidine and Irsogladine Maleate in Healthy Adult VolunteersCompletedPhase 1Boryung Pharmaceutical Co., LtdNCT02581696Written as Lafutidine
- Pharmacokinetic Properties and Effect of Food on Pharmacokinetic Properties of the Oral Lafutidine TabletsCompletedPhase 1Wuhan Union Hospital, ChinaNCT02658864Written as lafutidine
- Verification Study on Lafutidine in Mild Reflux Oesophagitis - Double Blind Controlled Study With Famotidine -CompletedPhase 3Taiho Pharmaceutical Co., Ltd.NCT00229424Written as Lafutidine
Codes
What other systems call lafutidine · ClinicalTrials.gg INT003660
- MeSH (NLM) C076948lafutidineConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) 49S4O7ADLCLAFUTIDINE, (+/-)-Confirmed FDA, NLM, Wikidata
- Wikidata Q582556lafutidineConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C79117LafutidineOne source FDA
- DrugBank DB12770One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C076948 | lafutidine | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | 49S4O7ADLC | LAFUTIDINE, (+/-)- | Confirmed FDA, NLM, Wikidata |
| Wikidata | Q582556 | lafutidine | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C79117 | Lafutidine | One source FDA |
| DrugBank | DB12770 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.